Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
MDMDxHealth S.A. logo

MDxHealth S.A. (MDXH)

NASDAQ Capital Market · Currency in USD
$0.18 ▼ 0.00 (-0.38%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.19 ▲ +0.01 (+3.66%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$0.18
Open
$0.18
Day's Range
$0.18 – $0.19
52 Week Range
$0.17 – $5.33
Volume
646,658
Avg. Volume
4,552,694
Market Cap
$17.49M
Beta (5Y Monthly)
0.39
PE Ratio (TTM)
--
EPS (TTM)
-$0.58
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$2.50

Profile: MDxHealth S.A.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
364
CEO
Michael K. McGarrity

MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative genomic testing portfolio for prostate cancer comprises SelectMDx, a non-invasive urine test, and ConfirmMDx, an epigenetic diagnostic tool.

Earnings

DateEst.Actual
Aug 13, 2026-$0.19-$0.18Beat
May 13, 2026-$0.13-$0.19Miss
Nov 12, 2025-$0.12-$0.16Miss
May 14, 2025-$0.13-$0.19Miss
Nov 6, 2024-$0.27-$0.40Miss
May 1, 2024-$0.30-$0.31Miss

Analyst view

Consensus price target
$2.50 ▲ +1,263.9%
Range $2.00 – $3.00
Rating: Buy
Buy 83% · Hold 17% · Sell -0%

Get free alerts on MDXH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.